NCT07650162

Brief Summary

Beta-alanine is a dietary supplement that increases skeletal muscle carnosine concentration and may enhance the muscle's ability to buffer hydrogen ions produced during high-intensity exercise. This buffering effect could potentially delay fatigue and improve exercise performance, particularly under conditions that increase metabolic stress, such as hypoxia. However, previous studies examining the effects of beta-alanine supplementation on repeated sprint performance under hypoxic conditions have produced inconsistent findings. The purpose of this study is to determine whether four weeks of beta-alanine supplementation improves repeated high-intensity cycling performance and influences markers of acid-base balance in trained male cyclists exercising under normoxic and hypoxic conditions. Participants will perform repeated Wingate anaerobic cycling tests before and after a four-week supplementation period with either beta-alanine or placebo. Mechanical performance outcomes, including peak power, mean power, total work, and fatigue indices, will be assessed alongside physiological measures of metabolic stress, including blood lactate concentration, pH, bicarbonate concentration, and base excess. Performance and physiological responses will be compared between supplementation groups and environmental conditions. The findings of this study may contribute to a better understanding of the ergogenic potential of beta-alanine supplementation during repeated high-intensity exercise and provide practical information for athletes and practitioners regarding the effectiveness of beta-alanine under conditions of reduced oxygen availability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2019

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

6.5 years

First QC Date

June 10, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

muscle bufferinganaerobic performanceWingate testacid-base balancehypoxiacyclists

Outcome Measures

Primary Outcomes (1)

  • Mean Power (W)

    4 weeks

Secondary Outcomes (11)

  • Peak Power (W)

    4 weeks

  • Relative Peak Power (W·kg-¹)

    4 weeks

  • Total Work (J)

    4 weeks

  • Fatigue Slope (W·s-¹)

    4 weeks

  • Rate of Fatigue (%)

    4 weeks

  • +6 more secondary outcomes

Study Arms (4)

BA-N

EXPERIMENTAL

Beta-alanine + normoxia

Dietary Supplement: beta-alanineOther: normoxic conditions

PL-N

PLACEBO COMPARATOR

Placebo + normoxia

Other: normoxic conditionsDietary Supplement: Placebo

BA-H

EXPERIMENTAL

Beta-alanine + hypoxia

Dietary Supplement: beta-alanineOther: Normobaric hypoxic conditions (≈2500 m)

PL-H

EXPERIMENTAL

Placebo + hypoxia

Dietary Supplement: PlaceboOther: Normobaric hypoxic conditions (≈2500 m)

Interventions

beta-alanineDIETARY_SUPPLEMENT

β-alanine (6 g·day-¹)

Also known as: BA
BA-HBA-N

normoxic conditions

Also known as: N
BA-NPL-N
PlaceboDIETARY_SUPPLEMENT

Placebo (6 g·day-¹)

PL-HPL-N

Normobaric hypoxic conditions (≈2500 m)

Also known as: H
BA-HPL-H

Eligibility Criteria

Age20 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male participants aged 20-50 years
  • Regularly riding a bike (min. 5000 km on the bike in the last year)
  • Willingness to maintain habitual dietary and physical activity patterns throughout the study.
  • Willingness to refrain from consuming dietary supplements other than those provided as part of the study.

You may not qualify if:

  • Prevalence of chronic diseases
  • β-alanine supplementation within the previous six months
  • Use of other dietary supplements, except carbohydrate and whey protein supplements
  • Adherence to a vegetarian or vegan diet
  • Participation in another clinical trial within the previous 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academy of Physical Education in Katowice

Katowice, Poland

Location

MeSH Terms

Conditions

Hypoxia

Interventions

beta-AlanineProtons

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AlanineAmino AcidsAmino Acids, Peptides, and ProteinsCations, MonovalentCationsIonsElectrolytesInorganic ChemicalsHydrogenElementsGasesNucleonsElementary ParticlesPhysical Phenomena

Study Officials

  • Mateusz Gawelczyk, PhD

    Institute of Sport Sciences, Academy of Physical Education, 40-065 Katowice, Poland

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Model Details: Participants performed three consecutive 30-s Wingate tests under normoxic or normo-baric hypoxic conditions (≈2500 m). Following baseline testing, participants consumed either β-alanine (6 g·day-¹) or placebo for four weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 16, 2026

Study Start

November 20, 2019

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

June 17, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Anonymised data will be available upon reasonable request.

Shared Documents
STUDY PROTOCOL

Locations